This is why these medications, initially developed to treat diabetes, have proved effective for treating obesity, cardiovascular disease, and even obstructive sleep apnea
10.3945/ajcn.114.087692 48 MissimerA.FernandezM
A new retail metabolic wellness lane and higher consumer expectations Labels move from high protein and good source of fibre to supports satiety, with on-pack summaries and QR links to readable study briefs
[ 5 ] The mechanism of action of DSIP, however, remains unclear
The European Food Safety Authority (EFSA) has approved a novel synthetic EGT at a dose of 30 mg/day for adults
Image: Olivier Le Moal/Getty Images About the Author Maureen Salamon, Executive Editor, Harvard Women's Health Watch About the Reviewer Robert H